WHO suspends trial of hydroxychloroquine as COVID-19 treatment over safety concerns

The World Health Organisation (WHO) on Monday announced a temporary suspension of the trial of hydroxychloroquine for the treatment of coronavirus patients.

The suspension of the trial,  it said, was due to a higher mortality rate among patients receiving the drug.

The WHO announced this during its media briefing at its headquarters in Geneva, Switzerland.

The decision came after the publication last week of a study in the Lancet indicating that the using the drug on COVID-19 patients could increase their likelihood of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference, adding that the WHO-backed trials had been “suspended while the safety is reviewed.”

Nigeria Has Recorded 229 New Cases Of Covid—19

Nigeria has recorded 229 new cases of coronavirus, bringing the total number of confirmed infections in the country to 8,068.

The Nigeria Centre for Disease Control made this known on Monday.

229 new cases of #COVID19;

Lagos-90
Katsina-27
Imo-26
Kano-23
FCT-14
Plateau-12
Ogun-9
Delta-7
Borno-5
Rivers-5
Oyo-4
Gombe-3
Osun-2
Anambra-1
Bayelsa-1

8068 cases of #COVID19 in Nigeria
Discharged: 2311
Deaths: 233